Download Curriculum Vitae

Curriculum Vitae
12/18/15
James Michael Wilson, M.D.
Personal Information
D.O.B.:
Birthplace:
Professional
Address:
Email:
10/20/64
Alexandria, LA USA
6624 Fannin, Ste. 2190
Houston, TX 77030
(832)-366-1530
[email protected]
Education
University:
Medical School:
Residency:
Fellowship:
Louisiana Tech Univ., Ruston, LA 1986 B.S. Microbiology.
Tulane University School of Medicine, New Orleans, LA 1990.
Internal Medicine, Baylor Coll. of Medicine, Houston, TX 1993
Cardiovascular Disease, Texas Heart Institute/Baylor Coll. of Med,
Houston, TX 1997
Academic Appointments
Robert J. Hall Chair of Cardiovascular Disease
Director of Cardiology Education, Baylor College of Medicine/St. Luke’s Episcopal
Hospital/Texas Heart Institute (Baylor Program 2)
Assistant Chief of Cardiology, CHI Baylor St. Luke’s Medical Center
Professor of Medicine, Baylor College of Medicine
Department of Internal Medicine, Division of Cardiology
Honors and Awards
Lambda Sigma Honor Society
Alpha Epsilon Delta Pre-Medical Honor Society
Phi Kappa Phi Honor Society
Alpha Omega Alpha Medical Honor Society
Paracelsus Award for excellence in Toxicology
John Taylor Halsey Award for excellence in Pharmacology
Chief Medical Resident for St. Luke's Episcopal Hospital 1994
Chief Cardiology Fellow 1996
Outstanding Cardiology Fellow 1997
Resident Teaching Award, Baylor College of Medicine 1999-2003, 2007
Robert J. Hall Teaching Award - 2007
Board Certification
National Board (Part I)
National Board (Part II)
Federal Licensing Examination
American Board of Internal Medicine
Cardiovascular Disease 1998, 2008
Certificate of Added Qualification for Interventional Cardiology 1999
Other non-academic positions
Chief of Staff CHI Baylor St. Luke’s Medical Center (2014-15)
Director Clinical Cardiovascular Services CHI Baylor St. Luke’s Medical Center
Director Heart Sounds Laboratory Texas Heart Institute
Professional Staff Texas Heart Institute
Research Support
“Magnetic Resonance Imaging of the Heart in the Diagnosis of Myocardial Infarction
and Myocardial Viability”. McDonald Foundation 1999-2000. (Co-Principle
Investigator). Direct Cost $20,000. Grant
“The use of coagulation times for monitoring anticoagulant therapy with low molecular
weight heparins during PCI.” Pharmacia Corporation. Peapack, NJ (Principle
Investigator) 1999-2000. Principle Investigator. Direct Cost $70,000. Contract.
“Murmur Detection and Diagnosis Using Digital Recording and Analysis”. Zargis Medical
Corporation. Princeton, NJ. 2003. Principle Investigator. Direct Cost $17,000.
Contract.
“Detection and Diagnosis of Diastolic Filling Sounds Diagnosis Using Digital Recording
and Analysis”. Zargis Medical Corporation. Princeton, NJ. 2005. Principle
Investigator. Direct Cost $15,000. Contract.
“Database Analysis of Outcomes After Drug Eluting Stent Coronary Revascularization”.
J&J Cordis, Miami, FL. 2003-2005. Principle Investigator. Direct Cost $100,000.
Contract.
Participation in multicenter trials provided on request.
National Scientific Participation
Journal Editorial Boards
Editorial Board:
Reviewer:
Texas Heart Institute Journal
Clinical and Applied Thrombosis/Hemostasis
Circulation
Catheterization and Cardiovascular Cardiology
Yonsei Medical Journal
Professional Societies
Texas Heart Institute Cardiac Society
Member-at-Large 1998
Vice President 1999
President 2000
American Medical Association
American College of Cardiology
Fellow
Counselor – Texas Chapter 2003 - current
American College of Physicians- Member
Texas Association of Internists
International Academy of Clinical and Applied Thrombosis/Hemostasis
Texas Club of Cardiologists
Society of Chest Pain Centers
Publications
Journals
1.
2.
3.
4.
5.
6.
7.
8.
9.
Wilson JM, Ferguson JJ: The therapeutic potential of abcirximab (c7E3 Fab) in
percutaneous transluminal coronary angioplasty: Implications of the EPIC study.
Clin Immunother 1994; 1(1):1-7.
Wilson JM, Silberman H, Ferguson JJ: Abrupt vascular closure. Journal of
Invasive Cardiology 1994; 6:306-313.
Wilson JM, Dougherty KG, Ellis KO, Ferguson JJ: Activated clotting times in
acute coronary syndromes and percutaneous coronary angioplasty. Cathet
Cardiov Diag 1995; 34:1-5.
Wilson JM, Ferguson JJ: Revascularization therapy for coronary artery disease.
Coronary artery bypass grafting versus percutaneous transluminal coronary
angioplasty. Tex Heart Inst J 1995; 22:145-161.
Ferguson JJ, Barasch E, Wilson JM, et al.: The relation of clinical outcome to
dissection and thrombus formation during coronary angioplasty. J Inv Cardiol
1995; 7:2-10.
Ferguson JJ, Dohmen P, Wilson JM, Vaughn WK, Khoshnevis R, Kmonicek P,
McKinney AA, Plachetka JR: Results of a national survey on anticoagulation for
PTCA. J Invas Cardiol 1995; 7:136-141.
Barasch E, Conger JL, Peters JJ, Nesdahl K, Fenimore JG, Wilson JM,
Ferguson JJ: PTCA in angulated segments: Effects of balloon material, balloon
length, and inflation sequence on straightening forces in an in-vitro model.
Cathet Cardiov Diagn 1996; 39:207-212.
Wilson JM, Kalife G, Rogers M, Strickman N, Massumi AM: An unusual
electrocardiographic presentation of right ventricular infarction. THI Journal
1996;4:305-9.
Ferguson JJ, Waly H, Le D, Thomakos N, Wilson JM. The effect of body weight
and body surface area connection on the distribution of the ACT response to
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
21.
22.
23.
24.
25.
bolus doses of heparin for PTCA. J Inv Cardiol 1998;10:318-22.
Wilson JM. Reversible congestive heart failure caused by myocardial
hibernation. Tex Heart Inst J 1999; 26:19-27.
Wilson JM, Ferguson JJ. Platelet-endothelial interactions in atherothrombotic
disease: therapeutic implications. Clin Cardiol 1999; 22:687-98.
Ferguson JJ, Thomakos N, Lau TK, Wilson JM. Overview of oral glycoprotein
IIb/IIIa antagonist therapy in vascular disease. J Invasive Cardiol. In Press.
Angelini P, Vaughn WK, Zaqqa M, Wilson JM, Fish RD. Impact of the "stentwhen-feasible" policy on in-hospital and 6-month success and complication rates
after
coronary
angioplasty:
single-center
experience
with
17,956
revascularization procedures (1993-1997). Tex Heart Inst J. 2000;27(4):337-45.
Villareal R, Achari A, Wilansky S, Wilson JM. Dynamic left ventricular outflow
tract obstruction secondary to myocardial stunning. Mayo Clinic Proceedings
2001;76:79-83.
Villareal RP, Kim P, Ferguson JJ 3rd, Wilson JM. Unstable angina and non-STsegment elevation myocardial infarction: perspectives on combination therapy.
Tex Heart Inst J. 2001;28(4):276-87.
Wilson JM, Villareal RP, Hariharan R, Massumi AG, Muthupillai R, Flamm SD.
Magnetic Resonance Imaging of Myocardial Fibrosis in Hypertrophic
Cardiomyopathy. Tex Heart Inst J 2002;29:176-80.
Villareal RP, Lee VV, Elayda M, Hall RJ, Wilson JM. Coronary artery bypass
surgery versus coronary stenting: risk-adjusted survival rates in 5,619 patients.
Tex Heart Inst J 2002;29(1): 3-9.
Villareal RP, Hariharan R, Liu BC, Kar B, Lee VV, Elayda M, Lopez JA, Rasekh
A, Wilson JM, Massumi A. Postoperative atrial fibrillation and mortality after
coronary artery bypass surgery. : J Am Coll Cardiol. 2004 Mar 3;43(5):742-8.
Nemeth MA, Muthupillai R, Wilson JM, Flamm SD. Cardiac Sarcoidosis
Detected by Delayed-Hyperenhancement Magnetic Resonance Imaging. Tex
Heart Inst J. 2004; 31(1):99-102.
Muthupillai R, Flamm SD, Wilson JM, Pettigrew RI, Dixon WT. Acute Myocardial
Infarction: Tissue Characterization with T1{rho}-weighted MR Imaging--Initial
Experience. Radiology. 2004;232:606-10.
Wilson JM. Stents or surgery: the case for stents. Tex Heart Inst J.
2005;32(3):331-8.
Wilson JM, Gilbert J, Harlan M, Bracey A, Allison P, Schooley C, Pinto K. Highdose intravenous dalteparin can be monitored effectively using standard
coagulation times.Clin Appl Thromb Hemost. 2005 Apr;11(2):127-38.
Frank CM, Palanichany N, Kar B, Wilson JM, Gregoric ID, Loyalka P, Civitello
AB. Use of a percutaneous ventricular assist device for treatment of cardiogenic
shock due to critical aortic stenosis. Tex Heart Inst J. 2006;33(4):487-9.
Mitchell J, Hadden TB, Wilson JM, Achari A, Muthuuupillai R, Flamm SD.
Clinical Features and Usefulness of Cardiac Magnetic Resonance Imaging in
Assessing Myocardial Viability and Prognosis in Takotsubo Cardiomyopathy
(Traisient Left Ventricular Apical Ballooning Syndrome) Am J Cardiol
2007;100(2), 296-301.
Kohsaka S, Goto M, Virani S, Lee, VV, Aoki N, Elayda M, Reul, R., Wilson JM.
26.
27.
28.
29.
30.
31.
32.
33.
34.
35.
36.
37.
38.
Long-Term Clinical Outcome of Coronary Artery Stenting or Coronary Artery
Bypass Grafting in Patients with Multiple Vessel Disease. J of Thoracic and CV
Surg 2008 Aug;136(2):500-6.
Frank CM, Palanichamy N, Kar B, Wilson JM, Gregoric ID, Loyalka P, Civitello
AB. Use of a Percutaneous Ventricular Assist Device for Treatment of
Cardiogenic Shock due to Critical Aortic Stenosis.
Tex Heart Inst J.
2006;33(4):487-9.
Ferguson JJ, Wilson JM, Diez J. Antithrombotic therapy and the transition to
the catheterization laboratory in UA/NSTEMI.
Minerva Cardioangiol.
2007;55:529-56.
Lubanda JCM, Palacek T, Trckova R, Wilson JM, Linhart A.
Preload
Dependence of the Time Interval between Onset of Mitral Inflow and Early
Diastolic Mitral Annular Velocity: A Study in Healthy Subjects. Echocardiography:
A Jrnl. Of CV Ultracound & Allied Tech. 2008;25(3):249-254.
Goto M, Kohsaka S, Aoki N, Lee VV, Elayda MA, Wilson JM. Risk Stratification
after successful coronary revascularization.
Cardiovasc Revasc Med
9(2008)132-139.
Madan P, Elayda MA, Lee VV, Wilson JM. Predicting major adverse cardiac
events after percutaneous coronary intervention: the Texas Heart Institute risk
score. Am Heart J 2008;155(6):1068-74.
Virani SS, Nambi V, Lee VV, Elayda M, Reul R, Wilson JM, Ballantyne CM.
Does Preoperative Statin Therapy Improve Outcomes in Patients undergoing
Isolated Cardiac Valve Surgery? Am J Cardiol 2008;102:1235-1239.
Nazeri A, Massumi A, Rasekh A, Saeed M, Frank C, Wilson JM, Lopez JA,
Razavi M. Cardiac resynchronization therapy may improve symptoms of
congestive heart falure in patients without electrical or mechanical dyssynchrony.
Eurospace. 2009;11(1):86-8.
Virani SS, Nambi V, Razavi M, Lee VV, Elayda M, Wilson JM, Ballantyne CM.
Preoperative statin therapy is not associated with a decreased incidence of
postoperative atrial fibrillation in patients undergoing cardiac surgery. Am Heart J
2008;155(3):541-6.
Wilson JM. Diagnosis and treatment of acquired coronary artery disease in
adults. Postgrad Med J. 2009 Jul;85(1005):364-5. Review
Kohsaka S, Goto M, Virani S, Lee VV, Aoki N, Elayda MA, Reul RM, Wilson JM.
Long-term clinical outcome of coronary artery stenting or coronary artery bypass
grafting in patients with multiple-vessel disease. J Thorac Cardiovasc Surg.
2008 Aug;136(2):500-6.
Sanon S, Lee VV, Elayda M, Wilson J. Use of Aspirin Versus Clopidogrel Plus
Aspirin After Coronary Artery Bypass Graft Surgery. Clin Appl Thromb Hemost.
2008 Dec 15. [Epub ahead of print] 2009;15(5):540-544
Nazeri A, Massumi A, Wilson JM, Frank CM, Bensler M, Cheng J, Saeed M,
Rasekh A, Razavi M. Arrhythmogenicity of weight-loss supplements marketed
on the internet. Heart Rhythm. 2009 May;6(5):658-62. Epub 2009 Feb 14.
Weisberg AD, Weisberg EL, Wilson JM, Collard CD. Preoperative Evaluation
and Preparation of the Patient for Cardiac Surgery. Medical Clinics of North Vol
93 (5), 2009.
39.
40.
41.
42.
43.
44.
45.
46.
47.
48.
49.
50.
51.
52.
53.
Cheong BY, Muthupillai R, Wilson JM, Sung A, Huber S, Amin S, Elayda MA,
Lee VV, Flamm SD. Prognostic significance of delayed-enhanced magnetic
resonance imaging: survival of 857 patients with and without left ventricular
dysfunction. Circulation. 2009 Nov 24;120(21):2069-76. Epub 2009 Nov 9.
Madan P, Elayda MA, Lee VV, Wilson JM. Risk-prediction models for mortality
after coronary artery bypass surgery: Application to individual patients. Int J
Cardiol. 2010 Mar 2. [Epub ahead of print]
Díez JG, Wilson JM. Practical strategies for the management of anticoagulation
therapy: unsolved issues in the cardiac catheterization laboratory. Cardiovasc
Drugs Ther. 2010 Apr;24(2):161-74. Review.
Wilson JM. When relativity has no relevance. Tex Heart Inst J. 2010;37(2):15960.
Attallah A, Cheong BY, Bernicker E, Wilson JM. Cardiac chloroma: novel
presentation and subsequent diagnosis with cardiac magnetic resonance
imaging. Tex Heart Inst J. 2010;37(2):242-3.
Kohsaka S, Kimura T, Goto M, Lee VV, Elayda M, Furukawa Y, Fukushima M,
Komeda M, Sakata R, Willerson JT, Wilson JM, Kita T. Difference in patient
profiles and outcomes in Japanese versus American patients undergoing
coronary revascularization (collaborative study by CREDO-Kyoto and the Texas
Heart Institute Research Database). Am J Cardiol. 2010 Jun 15;105(12):1698704.
Nazeri A, Razavi M, Elayda MA, Lee VV, Massumi A, Wilson JM.
Race/Ethnicity and the incidence of new-onset atrial fibrillation after isolated
coronary artery bypass surgery. Heart Rhythm. 2010 Oct;7(10):1458-63.
Sanon, S., Lee V. V., Elayda, M., Wilson, JM. Use of Clopidogrel plus Aspirin
versus Aspirin Post-Coronary Artery Bypass Grafting. Clin Appl Thromb Hemost
2009:15:540-544.
May S, Wilson JM. The Comparative efficacy of Percutaneous and Surgical
Coronary Revascularization in 2009: A Review. Tex Heart Inst J.
2009;36(5):375-86.
Guha, A., Wilson JM. The Impact of Renal Insufficiency Upon Outcomes After
Coronary Revascularization. Tex Heart Inst J (in press)
Virani S, Nambi V, Lee VV, Elayda M, Pan W, Peterson L, Wilson JM, Willerson
JT, Ballantyne CM. Obesity: an independent predictor of in-hospital post
operative renal insufficiency among patients undergoing cardiac surgery? Tex
Heart Inst J 2009;36(6):540-5.
Alam M, Virani SS, Simpson L, Williams SB, Wilson JM. Cardiac sarcoidosis: A
clinical entity uncommonly recognized. Tex Heart Inst J. 2009;36(5):501-3.
Weisberg AD, Weisberg EL, Wilson JM, Collard CD. Preoperative Evaluation
and Preparation of the Patient for Cardiac Surgery. Anesthesiology Clin
27(2009)633-648.
Ashrith G, Elayda M, Wilson JM. Revascularization Options in Patients with
Chronic Kidney Disease. Tex Heart Inst J 2010;37(1):9-18.
Ahmed A, Gondi S, Cox C, Wang S, Stupin IV, Shankar KJ, Munir SM, Sobash
E, Brewer A, Ferguson JJ, Elayda MA, Casscells SW, Wilson JM., Circadian
Body Temperature Variability is an Indicator of Poor Prognosis in
54.
55.
56.
57.
58.
59.
60.
61.
62.
63.
64.
65.
66.
Cardiomyopathic Hamsters J Card Fail. 2010 Mar; 16(3):268-74
Virani SS, Nambi V, Polsani V, Lee VV, Elayda M, Kohsaka S, Pan W, Reul R,
Wilson JM, Petersen L, Willerson JT, Ballantyne. Preoperative Statin Therapy
Decreases Risk of Postoperative Renal Insufficiency. Cardiovas Ther
2010;28:80-86.
Wilson JM. STEMI Limbo: Chasing a hard Target. Tex Heart Inst J
2010;37(3):312-315.
Wilson JM. Unintended Consequences: Avoiding Resentosis and Stent
Thrombosis. (Editorial Commentary) Tex Heart Inst J 2010;37(3):341-342.
Wilson JM. Race/Ethnicity and the Incidence of New-Onset Atrial Fibrillation
After Isolated Coronary Artery Bypass Surgery. Heart Rhythm J (in press)
Wilson JM, Birnbaum Introducing a New Algorithm in Inferior ST-Segment
Elevation Myocardial Infarction to Predict the Culprit Artery and Distinguish
Proximal Versus Distal Lesions.. Coronary Artery Disease (in press)
Huang HD, Tran V, Jneid H, , Wilson JM, Birnbaum Y. Comparison of
Angiographic Findings in Patients With Acute Anteroseptal Versus Anterior Wall
ST-Elevation Myocardial Infarction. Am J Cardiol. 2011 Mar 15;107(6):827-32.
Epub 2011 Jan 19.
Ashrith G, Lee VV, Elayda MA, Reul RA, Wilson JM. Short- and Long-Term
Outcomes of Coronary Artery Bypass Grafting or Drug-Eluting Stent Implantation
for Multivessel Coronary Artery Disease in Patients With Chronic Kidney
Disease. American Journal of Cardiology 2010;106(3): 348-353.
Virani SS, Brautbar A, Lee VV, Elayda M, Sami S, Nambi V Frazier L, Wilson
JM, Willerson JT, Boerwinkle E, Ballantyne CM. Usefulness of Single Nucleotide
Polymorphism in Chromosome 4q25 to Predict In-Hospital and Long Term
Development of Atrial Fibrillation and Survival in Patients Undergoing Coronary
Artery Bypass Grafting. Am J Cardiol. 2011 May 15;107(10):1504-9.
Alam M, Siddiqui S, Lee VV, Elayda MA, Nambi V, Yang EY, Jneid HM, Wilson
JM, Ballantyne CM, Virani SS. Isolated Coronary Artery Bypass Grafting in
Obese Individuals. Circ J. 2011 May 25;75(6):1378-85.
Hira RS, Wilson JM, Birnbaum Y. Introducing a new algorithm in inferior STsegment elevation myocardial infarction to predict the culprit artery and
distinguish proximal versus distal lesions. Coron Artery Dis. 2011
May;22(3):165-70.
Tran V, Huang HD, Diez JG, Kalife G, Goswami R, Paniagua D, Jneid H, Wilson
JM, Sherron SR, Birnbaum Y. Differentiating ST-Elevation Myocardial Infarction
from Nonischemic ST-Elevation in Patients With Chest Pain. Am J Cardiol. 2011
Jul 24. [Epub ahead of print]
Birnbaum Y, Wilson JM, Nikus K. Appropriate cardiac catheterization laboratory
activation: Optimizing electrocardiogram interpretation and clinical decision
making for acute ST-elevation myocardial infarction. Am Heart J. 2011
Jul;162(1):e3
Ahmed A, Gondi S, Cox C, Zheng M, Mohammed A, Stupin I, Wang S, Vela D,
Brewer A, Elayda M, Buja LM, Casscells SW, Wilson JM. Body Temperature
Circadian Rhythm Variability Corresponds to Left Ventricular Systolic Dysfunction
in Decompensated Cardiomyopathic Hamsters. J Card Fail. 2011
67.
68.
69.
70.
71.
72.
73.
74.
75.
76.
77.
78.
79.
Nov;17(11):937-43.
Tran V, Huang HD, Diez JG, Kalife G, Goswami R, Paniagua D, Jneid H, Wilson
JM, Sherron SR, Birnbaum Y. Differentiating ST-Elevation Myocardial Infarction
from Nonischemic ST-Elevation in Patients With Chest Pain. Am J Cardiol. 2011
Jul 24. [Epub ahead of print]
Munir M, Aliota J, Ahmed A, Mohammed A, Lee VV, Elayda M, Wilson JM,.
Sirolimus-eluting stents versus bare-metal stents in routine clinical use: a
nonrandomized comparison. Tx Heart Inst J. 2011;38(5):508-15.
Goto M, Kohsaka S, Lee VV, Elayda MA, Aoki N, Wilson JM. Risk stratification
of coronary revascularization patients by using clinical and angiographic data. J
Cardiovasc Surg (Torino). 2011 Dec;52(6):863-71.
Alam M, Lee VV, Elayda MA, Shahzad SA, Yang EY, Nambi V, Jneid H, Pan W,
Coulter S, Wilson JM, Ramanathan KB, Ballantyne CM, Virani SS. Association
of gender with morbidity and mortality after isolated coronary artery bypass
grafting. A propensity score matched analysis. Int J Cardiol. 2012 Jan 10. [Epub
ahead of print]
Kohsaka S, Goto M, Nagai T, Lee VV, Elayda M, Furukawa Y, Fukushima M,
Komeda M, Sakata R, Ohsugi M, Fukuda K, Wilson JM, Kita T, Kimura T.
Impact of diabetes among revascularized patients in Japan and the u.s.
Diabetes Care. 2012 Mar;35(3):654-9.
Virani SS, Brautbar A, Lee VV, Elayda M, Morrison AC, Grove ML, Nambi V,
Frazier L, Wilson JM, Willerson JT, Boerwinkle E, Ballantyne CM. Chromosome
9p21 Single Nucleotide Polymorphisms Are Not Associated With Recurrent
Myocardial Infarction in Patients With Established Coronary Artery Disease. Circ
J. 2012;76(4):950-6.
Mehta N, Huang HD, Bandeali S, Wilson JM, Birnbaum Y. Prevalence of acute
myocardial infarction in patients with presumably new left bundle-branch block. J
Electrocardiol. 2012 45(4):361-7.
Kayani WT, Huang HD, Bandeali S, Wilson JM, Virani S, Birnbaum Y. ST
elevation: Telling pathology from the benign patterns. Glob J Health Sci 2012;
4:51-63.
Satya K, Kalife G, Navarijo J, Rasekh A, Wilson JM. Transseptal Biopsy of a
Left Atrial Mass with Three-Dimensional Transesophageal Echocardiographic
Guidance. Tex Heart Inst J 2012;39(5):707-10..
Fernandes, MR, Fish RD, Canales J, Aliota J, Silva GV, Perin EC, Elayda MA,
Wilson JM. Restoration of Microcirculatory Patency after Myocardial Infarction.
Tx Heart Inst J 2012;39(3):342-50.
Bandeali SJ, Kayani WT, Lee VV, Pan W, Elayda MA, Nambi V, Jneid HM, Alam
M, Wilson JM, Birnbaum Y, Ballantyne CM, Virani SS.
Outcomes of
Preoperative Angiotensin-Converting Enzyme Inhibitor Therapy in Patients
Undergoing Isolated Coronary Artery Bypass Grafting. Am J Cardio 2012 Oct
1;110(7):919-23.
Ganjehei L, Wilson JM. Anticoagulants for Stroke Prevention in Nonvalvular
Atrial Fibrillation. Tex Heart Inst J 2012;39(4):517-525.
Cevik C, Shah N, Wilson JM, Stainback RF. Multiple Left Ventricular Thrombi in
a patient with Left Ventricular Noncompaction (Case Report). Tex Heart Inst J
80.
81.
82.
83.
84.
85.
86.
87.
88.
89.
90.
91.
92.
2012:39(4):550-3.
Kayani WT, Bandeali SJ, Lee VV, Pan W, Elayda MA, Khan A, Nambi V, Jneid
HM, Alam M, Wilson JM, Huang HD, Birnbaum Y, Ballantyne CM, Virani SS.
Association between statins and infections after coronary artery bypass grafting.
Int J Cardiol. 2012 Oct 6
Ganjehei L, Massumi A, Razavi M, Wilson JM. Orthostatic hypostension as a
manifestation of vitamin b(12) deficiency. Tex Heart Inst J. 2012;39(5):722-3.
Diffuse ST Depression with ST Elevation in aVR: Is this Pattern Specific for
Global Ischemia Due to Left Main coronary Artery Disease? In Press J of
Electrocardiology.
Bandeali S, Wilson JM. Association Between Preoperative Diuretic Use and Inhospital Outcomes After Cardiac Surgery. Accepted for publication in
Cardiovascular Therapeutics.
Sanon S, Lee VV, Elayda MA, Gondi S, Livesay JJ, Reul GJ, Wilson JM.
Predicting Early Death after Cardiovascular Surgery.
Tex Heart Inst J
2013:40(2):156-62.
Bandeali SJ, Kayani WT, Lee VV, Elayda M, Alam M, Huang HD, Wilson JM,
Jneid H, Birnbaum Y, Deswal A, Farmer J, Ballantyne CM, Virani SS.
Association Between Preoperative Diuretic Use and In-hospital Outcomes After
Cardiac Surgery. Cardiovasc Ther. 2013 Mar 20. doi: 10.1111/1755-5922.12024.
Alsaab A, Hira RS, Alam M, Elayda M, Wilson JM, Birnbaum Y. Usefulness of T
wave inversion in leads with ST elevation on the presenting electrocardiogram to
predict spontaneous reperfusion in patients with anterior ST elevation acute
myocardial infarction.Am J Cardiol. 2014
Moore C, Addison D, Wilson JM, Zeluff B. First case of Fusobacterium
necrophorum endocarditis to have presented after the 2nd decade of life.Tex
Heart Inst J. 2013;40(4):449-52.
Nascimbene A, Joggerst S, Reddy KJ, Cervera RD, Ott DA, Wilson JM,
Stainback RF. Aortic valve regurgitation that resolved after a ruptured coronary
sinus aneurysm was patched. Tex Heart Inst J. 2013;40(4):489-92.
Hojjati MR, Muthupillai R, Wilson JM, Preventza OA, Cheong BY. Assessment
of perfusion and wall-motion abnormalities and transient ischemic dilation in
regadenoson stress cardiac magnetic resonance perfusion imaging.Int J
Cardiovasc Imaging. 2014 Jun;30(5):949-57.
Virani SS, Lee VV, Brautbar A, Grove ML, Nambi V, Alam M, Elayda M, Wilson
JM, Willerson JT, Boerwinkle E, Ballantyne CM.
Single nucleotide
polymorphisms in cholesteryl ester transfer protein gene and recurrent coronary
heart disease or mortality in patients with established atherosclerosis. Am J
Cardiol. 2013 Nov 1;112(9):1287-92.
Wei EY, Hira RS, Huang HD, Wilson JM, Elayda MA, Sherron SR, Birnbaum Y.
Pitfalls in diagnosing ST elevation among patients with acute myocardial
infarction. J Electrocardiol. 2013 Nov-Dec;46(6):653-9.
Virani SS, Lee VV, Brautbar A, Grove ML, Nambi V, Alam M, Elayda M, Wilson
JM, Willerson JT, Boerwinkle E, Ballantyne CM.
Single nucleotide
polymorphisms in cholesteryl ester transfer protein gene and recurrent coronary
heart disease or mortality in patients with established atherosclerosis. Am J
93.
94.
95.
96.
97.
98.
Cardiol. 2013 Nov 1;112(9):1287-92.
Moore C, Addison D, Wilson JM, Zeluff B. First case of Fusobacterium
necrophorum endocarditis to have presented after the 2nd decade of life. Tex
Heart Inst J. 2013;40(4):449-52. Review.
Nascimbene A, Joggerst S, Reddy KJ, Cervera RD, Ott DA, Wilson JM,
Stainback RF. Aortic valve regurgitation that resolved after a ruptured coronary
sinus aneurysm was patched. Tex Heart Inst J. 2013;40(4):489-92.
Alsaab A, Hira RS, Alam M, Elayda M, Wilson JM, Birnbaum Y. Usefulness of T
wave inversion in leads with ST elevation on the presenting electrocardiogram to
predict spontaneous reperfusion in patients with anterior ST elevation acute
myocardial infarction. Am J Cardiol. 2014 Jan 15;113(2):270-4.
Hojjati MR, Muthupillai R, Wilson JM, Preventza OA, Cheong BY. Assessment
of perfusion and wall-motion abnormalities and transient ischemic dilation in
regadenoson stress cardiac magnetic resonance perfusion imaging. Int J
Cardiovasc Imaging. 2014 Jun;30(5):949-57.
Hira RS, Moore C, Huang HD, Wilson JM, Birnbaum Y. T wave inversions in
leads with ST elevations in patients with acute anterior ST elevation myocardial
infarction is associated with patency of the infarct related artery. J Electrocardiol.
2014 Jul-Aug;47(4):472-7.
Bandeali SJ, Gosch K, Alam M, Kayani WT, Jneid H, Fiocchi F, Wilson JM, Chan
PS, Deswal A, Maddox TM, Virani SS. Coronary Artery Disease Performance
Measures and Statin Use in Patients With Recent Percutaneous Coronary
Intervention or Recent Coronary Artery Bypass Grafting (from the NCDR
PINNACLE Registry). Am J Cardiol. 2015 Apr 15;115(8):1013-8.
Abstracts
1.
2.
3.
4.
5.
Walton BL, Civitello AB, Wilson JM, Allison P, Bracey A, Ferguson JJ. Aspirin
Resistance in Patients With Coronary Artery Disease. (Abstract) ACC Scientific
Session, March 2002.
Schooley C, Gilbert JH, Harlan M, Bracey A, Coulter S, Wilson JM. Kinetics of
Intravenously Administered Dalteparin. (Abstract) ACC Scientific Session, March
2003.
Gupta K, Kadakia R, Villareal R, Lee V, Elayda M, Wilson JM. Long-term
Survival in Diabetic Patients after Coronary Revascularization with Stenting or
Coronary Artery Byapss Surgery. (Abstract) AHA Scientific Session, November
2003.
Walton BL, Civitello AB, Wilson JM, Allison P, Bracey A, Ferguson JJ. Aspirin
Resistance in Patients with Coronary Artery Disease. (Abstract) J Am Coll
Cardiol 2003 Mar 19 41(6):335A.
Gupta K, Kadakia R, Villareal R, Lee VV, Elayde M, Wilson JM. Long-Term
Survival in Diabetics Undergoing Coronary Revascularization is Equivalent with
Stent Placement and Bypass Surgery. (Abstract) Circulation 2003 Oct 28
108(17) 607.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
Schooley CC, Gilbert JH, Harlan M, Bracey A, Coulter, S, Wilson JM. Kinetics
of Intravenously administered Dalteparin (Abstract) J Am Coll Cardiol 2003 Mar
19 41(6):25A.
Buheis N, Lee VV, Elayda M, Wilson JM. Treatment of Saphenous Vein Graft
Lesions with Sirolimus-Eluting Stent: Immediate and Nine Month Outcome.
(Abstract) Circulation 2005 Oct 25 112(17) 478.
Munir MS, Ahmed AH, Brewer MA, Shankar KJ, Williams S, Casscells SW,
Wilson, JM. The effect of Percutaneous Coronay Intervention on Transcoronary
Lipoprotein associated Phospholipase A2 (Lp-PLA2) concentration. (Abstract
and Poster) International Society for Heart Research North American Section
Meeting 2006, June 13-16, 2006.
Munir MS, Ahmed AH, Brewer MA, Shankar KJ, Williams S, Cassells SW,
Wilson JM. The effect of percutaneous coronary intervention on transcoronary
lipoprotein-associated phospholipase A2 (LP-PLA2) concentration. (Abstract)
Journal of Molecular and Cellular Cardiology 40 (2006)898.
Munir MS, Ahmed AH, Brewer MA, Shankar KJ, Williams S, Casscells SW,
Wilson JM. The effect of percutaneous coronary intervention on transcoronary
lipoprotein-associated A2 (LP-PLA2) concentration. (Abstract and Poster)
presented at TCT 2005.
Kohsaka S, Lee VV, Goto M, Aoki N, Elayda MA, Wilson JM. Nine-Year Clinical
Outcome of Coronary Stenting Versus Coronary Artery Bypass Grafting in
Patients with Significant Proximal LAD Stenosis or Multiple Vessel. ACC 55th
Annual Scientific Sessions 2006, Atlanta, GA. Featured in i2 Summit press
conference
Goto M, Kohsaka S, Lee VV, Elayda MA, Wilson JM, Aoki N. Use of Decision
Tree Analysis for Clinical Risk Stratification in Revascularized Patients with
Multivessel or Proximal LAD Coronary Artery Disease. 7th Scientific Forum on
Quality of Care and Outcomes Research in Cardiovascular Disease and Stroke,
May 2006 Washington DC.
Munir MS, Delaughter C, Ahmed AH, Lee VV, Elayda MA, Wilson JM. A
comparison of short-and long-term outcomes of coronary artery disease patients
treated with Bare metal Stent or Bypass surgery. (Abstract) ACC March 24,
2007, New Orleans, LA.
Munir MS, Delaughter CM, Shankar KJ, Ahmed AH, Brewer AM, Lee VV, Elayda
MA, Casscells SW, Wilson JM. Comparison of short and mid-term outcomes of
patients with coronary artery disease (CAD) treated with Drug-eluting stents
(DES) and Coronary Artery Bypass Grafting. (Abstract and Poster) AHA
Atherosclerosis, Thrombosis and Vascular Biology Annual Conference 2007,
April 19-21, 2007, Chicago, Ill.
Munir MS, Delaughter CM, Shankar KJ, Ahmed AH, Lee VV, Elayda MA,
Casscells, SW, Wilson JM. Early Major Adverse Cardiac Events (MACE) and
long-term survival in patients treated with Bare Metal Stents (BMS) and Drug
Eluting Stents (DES). . (Abstract and Poster) AHA Atherosclerosis, Thrombosis
and Vascular Biology Annual Conference 2007, April 19-21, 2007, Chicago, Ill.
Virani SS, Elayda M, Nambi V, Wilson JM, Ballantyne CM. Pre-operative statin
therapy is not associated with decreased incidence of post-operative atrial
17.
18.
19.
20.
21.
22.
23.
24.
25.
26.
fibrillation in patients undergoing coronary artery bypass grafting. J Am Coll
Cardiol 2007;49(9):304(Supp A).
Virani SS, Elayda M, Nambi V, Wilson JM, Ballantyne CM. Does pre-operative
statin therapy improve outcomes in patients undergoing cardiac valve surgery? J
Am Coll Cardiol 2007;49(9):307(Supp A).
Mitchell JH, Hadden TB, Wilson JM, Achari A, Muthupillai R, Flamm SD.
Clinical Features and Usefulness of Cardiac Magnetic Resonance Imaging in
Assessing Myocardial Viability and Prognosis in Takotsubo Cardiomyopathy
(Transient Left Ventricular Apical Ballooning Syndrome) by American Journal of
Cardiology (Vol. 100, Issue 2, Pages296-301
Diez JG, Aliota J, Wilson JM, Elayda M. Safety and Efficacy in the use of
Enoxaparin as Antithrombin Therapy During Primary Percutaneous Coronary
Intervention for ST-Elevation Myocardial Infarction. Presented at 2008 CRT, Feb
11-13, 2008, Washington, DC.
Ahmed A, Gondi S, Munir M, Cox C, Shankar KJ, Stupin I, Sobash E, Engel S,
Asopa S, Lai D, Brewer A, Wilson J, Casscells SW. Utility of Continuous Body
Temperature Monitoring in Predicting Prognosis in Cardiomyopathic Hamsters.
Accepted for presentation at the 12th Annual Scientific meeting of the heart
Failure Society of America, Sept 21-24, 2008, Toronto, ON, Canada.
Amany Ahmed, Sreedevi Gondi, Shahzeb M. Munir, Casey Cox , K. J. Shankar,
Igor V. Stupin, Sabrina Engler, Shubha Asopa, Ed Sobash, Dejian Lai, Alan
Brewer, James M. Wilson, S. Ward Casscells. The Effect of External
Environment on the Predictive Value of Body Temperature in Cardiomyopathic
Hamsters. Presented at TCT 2008, October 12-17 in Washington DC.
Razavi M, Brewer A, Wilson JM, Stupin I, Saeed M, Rasekh A, Massumi A.
Validation Of A Novel Device For Prevention Of Pneumothorax During Vascular
Access. (abstract) American Heart Association's Resuscitation Science
Symposium 2008 in New Orleans, Louisiana Nov. 8-12, 2008.
Nazeri A, Wilson JM, Massumi A, Lee VV, Elayda M, Razavi M. Hispanic
Ethnicity Is an Independent Predictor of Stroke After Coronary Artery Bypass
Surgery (poster presentation) International Stroke Conference 2009, Orlando,
FL, February 18 - Friday, February 20, 2009 at the San Diego Convention
Center, San Diego, CA
Ahmed A, Gondi S, Cox C, Munir S, Shankar KJ, Stupin I, Sobash E, Lai D,
Brewer A, Wilson JM, Casscells SW. The Usefulness of Body Temperature
Circadian Rhythm Variation as an Early Predictor of Decompensation in
Cardiomyopathic Hamsters. Presentation at ACC, March 28-31, 2009, Orlando,
FL.
Ashrith G, Lee V, Elayda M, Wilson J, Reul R. Short- and Long-term Outcomes
of Coronary Artery Bypass Graft Surgery or Drug-eluting Stent Implantation for
Multivessel Coronary Artery Disease in Patients With Chronic Kidney Disease: A
Propensity Score Based Analysis. oral presentation at the AHA Scientific
Sessions 2009 in Orlando, Florida.
Alireza Nazeri, MD; James M. Wilson, MD, FACC; Vei-Vei Lee, MS; MacArthur
A. Elayda, MD, PhD; Ali Massumi, MD, FACC; Mehdi Razavi. Scoring System
Predicts New Atrial Fibrillation After Cardiac Surgery ", MD, Cardiostim, June
27.
28.
29.
30.
31.
2010, Nice-France.
Huang HD, Jneid H, Wilson JM, Birnbaum Y. Differences in Coronary Anatomy
Between Patients with Anteroseptal ST Elevation Myocardial Infarction.
(Abstract) Circulation 2010;122:A18906.
Mohammed A, Lombo B, Bavishi C, Fu Y, Wilson JM, Diez JG.
Clinical Factors And Texas Heart Pci Risk Score Correlate With Syntax Score
During Patient Selection For PCI or CABG. accepted for POSTER presentation
at CRT 2012.
Bandeali SJ, Kayani WT, Lee VV, Wei-Pan, Elayda M, Nambi V, Jneid H, Alam
M, Wilson JM, Farmer JA, Birnbaum Y, Ballantyne CM, Virani SS. Preoperative Angiotensin Converting Enzyme Inhibitor use and outcomes in patients
undergoing Isolated Coronary Artery Bypass Grafting. Abstract to be presented
at AHA QCOR May 2012 Atlanta.
Bandeali SJ, Kayani WT, Lee VV, Elayda M, Nambi V, Jneid H, Alam M, Wilson
JM, Birnbaum Y, Ballantyne CM, ViraniSS. The outcomes of pre-procedural
Angiotensin Converting Enzyme Inhibitor therapy in patients undergoing
Percutaneous Coronary Intervention. Abstract to be presented at AHA QCOR
May 2012 Atlanta.
Bandeali SJ, Gosch K, Negi SI, Alam M, Kayani WT, Wilson JM, Chan PS,
Deswal A, Maddox TM, Virani SS. Comparison of Compliance with Coronary
Artery Disease Performance Measures and Statin Use between Patients with
recent Percutaneous Coronary Intervention (PCI) and Patients with recent
Coronary Artery Bypass Grafting (CABG): An Analysis from the National
Cardiovascular Data Registry®." Abstract to be presented at NORTH WESTERN
YOUNG INVESTIGATOR AWARD COMPETITION to be held in September
2013
Book Chapters
1.
2.
3.
4.
5.
6.
Ferguson JJ, Wilson JM: Coronary Artery Bypass Surgery and Percutaneous
Transluminal Coronary Angioplasty. In Willerson JT, Cohn JN: Cardiovascular
Medicine, Churchill Livingstone, New York 1995:670-701.
Wilson JM: Anticoagulant Monitoring. In: Becker R, Textbook of Coronary
Thrombosis and Thrombolysis. Kluwer Academic Publishers 1997.
Ferguson JJ, Wilson JM. Anticoagulation Monitoring for Percutaneous
Transluminal Coronary Angioplasty. In: Becker R, Textbook of Coronary
Thrombosis and Thrombolysis. Kluwer Academic Publishers 1997.
Wilson JM, Hall RJ, Ferguson JJ: Coronary Artery Bypass Surgery and
Percutaneous Transluminal Coronary Angioplasty. In Willerson JT, Cohn JN:
Cardiovascular Medicine, Churchill Livingstone, New York 2000:670-701.
Wilson JM, Kim P, Ferguson JJ. Antiplatelet Drugs. In: Pifarre R SB, ed.
Evidence Based Management of the Acute Coronary Syndrome. (Book Chapter)
Philadelphia, PA: Hanley & Belfus, Inc., 2000.
Strickman N, Wilson JM: Peripheral vascular disease. In: Cardiovascular
Disease in Women. Eds: Wilansky SW, Willerson JT. 2001.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
Gupta K, Wilson JM, Ferguson JJ: Anticoagulation Monitoring. Textbook of
Clinical Interventional and Investigational Thrombocardiology. Ed: Becker RC.
2005.
Gupta K, Wilson JM, Ferguson JJ: Anticoagulation in Venous Thromboembolic
Diseases. Textbook of Clinical Interventional and Investigational
Thrombocardiology . Ed. Becker RC. 2005.
Gupta K, Wilson JM, Ferguson JJ: Chronic Oral Anticoagulation Therapy in
Cardiac Disease. Textbook of Clinical Interventional and Investigational
Thrombocardiology. Ed: Becker RC. 2005.
Strickman N, Wilson JM: Peripheral vascular disease. In: Cardiovascular
Disease in Women. Eds: Wilansky SW, Willerson JT. 2007.
Willerson, J.T., Wilson, JM. Myocardial Revascularization with Cardiologic
Interventional Devices.In: Cohn LH, Edmunds LH Jr, eds. Cardiac Surgery in the
Adult. New York: McGraw-Hill, 2007.
Wilson JM, Ferguson JJ, Hall RJ. Coronary Artery Bypass Surgery and
Percutaneous Coronary Revascularization: Impact on Morbidity and Mortality in
Patients with Coronary Artery Disease. Cardiovascular Medicine, Third Edition
Ed. Willerson, Cohn, Wellens, Holmes. 2007
Wilson JM, Willerson JT. Myocardial Revascularization with Percutaneous
Devices.
Díez JG, Wilson JM. Ventriculography / Aortography. In: Cardiac
Catheterization, Coronary and Peripheral Angiography, and Interventional
Procedures. 1st Ed. Editors: Debabrata Mukherjee, Eric R. Bates, Marco Roffi,
and David J. Moliterno. Informa Healthcare 2009.
Wilson JM, Willerson JT. Myocardial revascularization with percutaneous
devices. In: Cohn L, ed. Cardiac surgery in the adult. New York: McGraw Hill
Professional; 2012:461-478.
Wilson JM. Coronary Artery Bypass Surgery and Percutaneous Coronary
Revascularization: Impact on Morbidity and Mortality in Patients with Coronary
Artery Disease. Coronary Artery Disease Ed: Willerson JT, Holmes Jr DR. 2015.
Birnbaum U, Wilson JM, Nikus K. The Electrocardiogram in Coronary Artery
Disease. Coronary Artery Disease Ed: Willerson JT, Holmes Jr DR. 2015.
Editorial/Non-peer Review
1.
2.
3.
4.
Wilson JM, George WG, et al. "Toxicity of Dioxins", Open File No. 20.
Environmental Institute for Waste Management Studies - Publications, University
of Alabama 191pp. 1988
Barasch E, Wilson JM, Ferguson JJ: Anticoagulation and PTCA. Developments
in Cardiology 1994; 4(7):91-104.
Ferguson JJ, Wilson JM: Early and late ischemic complications of PTCA. J Inv
Cardiol 1994; 6 (Suppl A):3A-12A.
Khoshnevis R, Wilson JM, Ferguson JJ: Non-invasive imaging of the
cardiovascular system: Electron beam computed tomography and magnetic
resonance imaging. Current Opinion in Cardiology 1994, 9:729-739.
5.
6.
7.
8.
9.
Ferguson JJ, Waly HM, Wilson JM: Mechanism and role of platelets in ischemic
events: action of therapeutic agents. J Inv Card 1996, 8 (Suppl B):1B-7B.
Ferguson, J.J., H.M. Waly, and J.M. Wilson. Fundamentals of coagulation and
glycoprotein IIb/IIIa receptor inhibition. Am Heart J, 1998. 135(4): p. S35-42.
Ferguson, J.J., H.M. Waly, and J.M. Wilson. Fundamentals of coagulation and
glycoprotein IIb/IIIa receptor inhibition. Eur Heart J, 1998. 19 Suppl D: p. D3-9.
Wilson JM, Walton B. Lesions and lipids and radicals--O my! : Tex Heart Inst J.
2004;31(2):118-26.
Wilson, JM. A Day Without Orange Juice is Like an Invitation to Atrial Fibrillation
Tex Heart Inst J 2007;34:265-7.
Teaching
Resident Training: 10 hours/week
Clinical Fellow Training: 10 hours/week. Clinical Cardiology, Electrocardiography,
Interventional Cardiology. Names/Locations provided on request
Lectures- International
“Saphenous Vein Graft Disease”, Thailand Cardiovascular Society Scientific
Meeting, Bangkok, Thailand March 1998.
“The impact of diabetes mellitus upon long term outcome after surgical or
percutaneous revascularization” Mediterranean Cardiovascular Society Scientific
Meeting. Rhodes, Greece June 2002
“Treatment strategies based on optimizing laboratory markers in cardiology” 9 th
International Symposium on Thromboembolism. London, U.K. June 2003
“Percutaneous Revascularization in the diabetic”, Presented at the DeltaCardio
meeting of the Egyptian Cardiac Society, Alexandria, Egypt 2004
“Inflammation and Cardiovascular Disease”, Kuwait Cardiac Society, Kuwait City,
2005
“Drug Eluting Stents”, Kuwait Cardiac Society, Kuwait City, 2005
Lectures- National
Auscultation Seminar- Auscultation Faculty, San Antonio, TX 2000.
“Clinical Outcomes after Coronary Bypass Surgery and Percutaneous Coronary
Revascularization”, Grand Rounds Presentation at University of Texas Medical
Center at Tyler, TX. March 2000.
“Glycoprotein IIb/IIIa Antagonists in PCI and AMI”, Presented at The Cutting
Edge: A Cardiac & Vascular Update. Presbyterian Hospital of Dallas. Dallas, TX
December 2000.
“Low Molecular Weight Heparin in PCI”, Presented at Pharmacy and
Therapuetics Update. University Phamacotherapeutics Associates Meeting. San
Francisco, CA February 2003.
“Lp-PLA2 A Novel Risk Market for Coronary Artery Disease”, Case Manager
society Annual Meeting, Nashville, TN June 2004.
Lectures-Local
“Advances in the Management of Congestive Heart Failure”. Spring Auscultation
Seminar, Texas Heart Institute, 1999- 2000.
“Secondary Prevention of Myocardial Infarction”, Atlanta 1999.
“Myocardial Hibernation”, Heart Failure, Texas Heart Institute, 1998- 2000.
“Hospice for The Dying Patient”, Heart Failure, Texas Heart Institute, 2000.
“Magnetic Resonance Imaging of the Heart” Texas Heart Institute Symposium:
Advances in Cardiovascular Disease, Anaheim, CA 2000.
“Revascularization Therapy for Coronary Artery Disease” Texas Medical Center
Cardiology Board Review. Houston, TX 2004-5.
“Cardiovascular Physical Examination” Texas Medical Center Cardiology Board
Review. Houston, TX 2005.
Intramural Presentations
Cardiac Auscultation, Medical Student Lecture Series
Principles of Electrocardiography, Medical Student Lecture Series
Principles of Resuscitation, Medical Residency Core Lecture Series
Management of Acute Myocardial Infarction, Cardiology Core Lecture Series
Principles of Coronary Revascularization, Cardiology Core Lecture Series
Acute Coronary Syndromes, Cardiology Core Lecture Series. UT-Houston
Cardiology Training Program
Preparation of the Patient for Coronary Intervention, Interventional Cardiology
Lecture Series
High Risk Coronary Intervention, Interventional Cardiology Lecture Series
“Coronary Artery Disease”, Cardiovascular Surgery Core Lecture Series
Medical and Service Information
Direct patient care and resident supervision for private cardiology service
Voluntary Health Organization Participation
American Heart AssociationPhysician’s Volunteer Advisory Board 1999
Board of Directors, Houston Division 2003
Institutional, Departmental, and Divisional Administrative Responsibilities, Committee
Memberships, and Other Activities
Residency Service Evaluation Committee, Baylor College of Medicine 19992002.
Medical Student Elective Rotation Committee, Baylor College of Medicine 20002002.
Interventional Cardiology Curriculum Committee, Texas Heart Institute/Baylor
College of Medicine 2000- current.
Cardiology Fellowship Applicant Selection Committee, Texas Heart
Institute/Baylor College of Medicine 1998- current.
Cardiovascular Research Steering Committee, Texas Heart Institute 1999current.
Medical Executive Committee, St. Luke’s Episcopal Hospital 2000-2002, 2005.
Medical Executive Committee, Texas Heart Institute 2002-current.
CCU Committee, St. Luke’s Episcopal Hospital 1999-2002.
Chest Pain Unit Committee, St. Luke’s Episcopal Hospital/Texas Heart Institute
2000-.
Institutional Review Board for Research, St. Luke’s Episcopal Hospital 19992002.
Quality of Care Committee, St. Luke’s Episcopal Hospital 1999-2002.
Pharmacy and Therapeutics Committee, St. Luke’s Episcopal Hospital 1999-
Community Activities
Establishment of the “St. Luke’s/Episcopal Charities Cardiovascular Clinic” an indigent
clinic for the diagnosis and treatment of adult congenital and complex cardiovascular
disease- Physician director. 1997-2000